- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04014439
Relationship Between NLR and Prealbumin Levels With Diaphragm Thickness
December 30, 2019 updated by: Rudyanto Sedono, Indonesia University
Relationship Between Neutrophil to Lymphocyte Ratio and Prealbumin Serum Levels With Diaphragm Thickness in Critical Patients
A study to find the relationship between neutrophil to lymphocyte ratio (NLR) with diaphragm thickness of critical patients in ICU.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Weaning from ventilator sometimes can be failed and it happened due to several factors.
One of the causes was Ventilator Induced Diaphragm Dysfunction (VIDD).
This VIDD process occurred due to thinning process of the diaphragm thickness or decreased diaphragm muscle mass.
The whole process happened due to inflammatory reaction that usually appeared on patients in Intensive Care Unit (ICU).
Thus, this study was aimed to find the relationship between neutrophil to lymphocyte ratio (NLR) with diaphragm thickness of critical patients in ICU.
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Indonesia University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years to 70 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients who are treated in intensive care unit and using mechanical ventilation from Day 0 till Day 5.
These patients will be checked for their diaphragm thickness, level of prealbumin serums, and ratio of neutrophil to lymphocyte.
Description
Inclusion Criteria:
- Critical patients treated in intensive care unit using mechanical ventilation from day 0.
- Patients are clinically predicted to be treated for more than 5 days (qSOFA and clinical assessment)
Exclusion Criteria:
- History of suffering from neuromuscular disease and or diaphragmatic malformations
- Used non-invasive ventilation before starting to use mechanical ventilation
- History of tracheostomy
- Patients admitted to ICU within 12 months before this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Normal Diaphragm
Diaphragm thickness is 2 mm or more
|
Each patient was examined for a blood sample of 6 ml of venous blood taken from the cubital vein using a vacuum tube without anticoagulants.
Blood samples were centrifuged at a speed of 3500 rpm for 20 minutes.
Samples are processed with abbott® devices, to obtain neutrophil and serum lymphocyte levels.
Plasma samples are stored in the refrigerator -20 C. The patient's diaphragm thickness was measured on days 0, 3, 5 and then the measurement was compared.
Diaphragm thickness was measured in patients using mechanical ventilation in intensive care rooms.
Each patient was examined for a blood sample of 6 ml of venous blood taken from the cubital vein using a vacuum tube without anticoagulants.
Blood samples were centrifuged at a speed of 3500 rpm for 20 minutes.
Samples are processed with abbott® devices, to obtain neutrophil and serum lymphocyte levels.
Plasma samples are stored in the refrigerator -20 C. The patient's diaphragm thickness was measured on days 0, 3, 5 and then the measurement was compared.
Diaphragm thickness was measured in patients using mechanical ventilation in intensive care rooms.
|
|
Thinning Diaphragm
Diaphragm thickness is less than 2 mm
|
Each patient was examined for a blood sample of 6 ml of venous blood taken from the cubital vein using a vacuum tube without anticoagulants.
Blood samples were centrifuged at a speed of 3500 rpm for 20 minutes.
Samples are processed with abbott® devices, to obtain neutrophil and serum lymphocyte levels.
Plasma samples are stored in the refrigerator -20 C. The patient's diaphragm thickness was measured on days 0, 3, 5 and then the measurement was compared.
Diaphragm thickness was measured in patients using mechanical ventilation in intensive care rooms.
Each patient was examined for a blood sample of 6 ml of venous blood taken from the cubital vein using a vacuum tube without anticoagulants.
Blood samples were centrifuged at a speed of 3500 rpm for 20 minutes.
Samples are processed with abbott® devices, to obtain neutrophil and serum lymphocyte levels.
Plasma samples are stored in the refrigerator -20 C. The patient's diaphragm thickness was measured on days 0, 3, 5 and then the measurement was compared.
Diaphragm thickness was measured in patients using mechanical ventilation in intensive care rooms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Level of Prealbumin Serum
Time Frame: 5 days
|
5 days
|
|
Ratio of Neutrophil to Lymphocyte
Time Frame: 5 days
|
5 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rudyanto Sedono, Indonesia University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Li C, Li X, Han H, Cui H, Wang G, Wang Z. Diaphragmatic ultrasonography for predicting ventilator weaning: A meta-analysis. Medicine (Baltimore). 2018 Jun;97(22):e10968. doi: 10.1097/MD.0000000000010968.
- Flevari A, Lignos M, Konstantonis D, Armaganidis A. Diaphragmatic ultrasonography as an adjunct predictor tool of weaning success in patients with difficult and prolonged weaning. Minerva Anestesiol. 2016 Nov;82(11):1149-1157. Epub 2016 Jul 12.
- Conti G, Montini L, Pennisi MA, Cavaliere F, Arcangeli A, Bocci MG, Proietti R, Antonelli M. A prospective, blinded evaluation of indexes proposed to predict weaning from mechanical ventilation. Intensive Care Med. 2004 May;30(5):830-6. doi: 10.1007/s00134-004-2230-8. Epub 2004 Mar 20.
- Sellares J, Ferrer M, Cano E, Loureiro H, Valencia M, Torres A. Predictors of prolonged weaning and survival during ventilator weaning in a respiratory ICU. Intensive Care Med. 2011 May;37(5):775-84. doi: 10.1007/s00134-011-2179-3. Epub 2011 Mar 4.
- Khan J, Harrison TB, Rich MM. Mechanisms of neuromuscular dysfunction in critical illness. Crit Care Clin. 2008 Jan;24(1):165-77, x. doi: 10.1016/j.ccc.2007.10.004.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2019
Primary Completion (Actual)
December 1, 2019
Study Completion (Actual)
December 1, 2019
Study Registration Dates
First Submitted
July 8, 2019
First Submitted That Met QC Criteria
July 8, 2019
First Posted (Actual)
July 10, 2019
Study Record Updates
Last Update Posted (Actual)
January 2, 2020
Last Update Submitted That Met QC Criteria
December 30, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- IndonesiaUAnes037
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Response
-
Bayside HealthUMC UtrechtActive, not recruiting
-
Marinova Pty LtdUniversity of South Carolina; Nutrasource Pharmaceutical and Nutraceutical...Completed
-
National Taiwan Normal UniversityCompleted
-
Virginia Polytechnic Institute and State UniversityActive, not recruitingInflammatory ResponseUnited States
-
Utah State UniversityGreenAcres FoundationActive, not recruitingInflammatory ResponseUnited States
-
Assiut UniversityCompleted
-
Norma Osama Abdalla ZayedAbdelhamid, Bassant Mohamed, M.D.CompletedInflammatory ResponseEgypt
-
University of ViennaRecruiting
-
Utah State UniversityDuke University; United States Department of Agriculture (USDA)Active, not recruiting
Clinical Trials on Ratio of Neutrophil to Lymphocyte
-
Zekai Tahir Burak Women's Health Research and Education...UnknownEclampsia | PreeclampsiaTurkey
-
Clinica Universitaria Reina Fabiola, Universidad...CompletedAcute DiverticulitisArgentina
-
Centre Hospitalier Universitaire, AmiensCompletedBacterial InfectionsFrance
-
Tepecik Training and Research HospitalCompletedNeural Tube Defects | Newborn Sepsis
-
Sohag UniversityNot yet recruiting
-
Ain Shams UniversityCompletedUrinary Bladder Cancer | BCG | Urinary Bladder Neoplasm | Non-Muscle Invasive Bladder Urothelial Carcinoma | Trans Urethral Resection of a Bladder TumorEgypt
-
Clinica Universitaria Reina Fabiola, Universidad...Completed
-
Assiut UniversityCompletedCopd | COPD ExacerbationEgypt
-
Assiut UniversityCompleted
-
Ain Shams UniversityUnknown